Showing results (541-550 of 572) with videos related to

Sort By:
Pageof 58
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 18, 2022
Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic settingBurcu Isler, Berna Özer, Güle Çınar, et al.
The Lancet. Infectious Diseases|April 27, 2017
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez-Gutiérrez, Elena Salamanca, Marina de Cueto, et al.
The Journal of Antimicrobial Chemotherapy|February 25, 2016
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort studyBelén Gutiérrez-Gutiérrez, Robert A Bonomo, Yehuda Carmeli, et al.
Diagnostic Microbiology and Infectious Disease|July 17, 2022
Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolatesBurcu Isler, Cansel Vatansever, Berna Özer, et al.
Infection Control and Hospital Epidemiology|April 6, 2018
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniaeOded Scheuerman, Vered Schechner, Yehuda Carmeli, et al.
The Lancet. Infectious Diseases|October 9, 2025
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trialDavid L Paterson, Helmi Sulaiman, Po-Yu Liu, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant Pseudomonas aeruginosa and clinical implications in the prospective observational Pseudomonas studyLee S Gottesdiener, Yixuan Li, Kerryl E Greenwood-Quaintance, et al.
JAMA|September 13, 2018
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical TrialPatrick N A Harris, Paul A Tambyah, David C Lye, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing EnterobacteriaceaeBelén Gutiérrez-Gutiérrez, Salvador Pérez-Galera, Elena Salamanca, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT CohortZaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Esther Calbo, et al.
Pageof 58